| abstract |
The present invention relates to methods and products for the transepithelia l systemic delivery of therapeutics. In particular, the invention relates to methods and compositions for the systemic delivery of therapeutics by administering an aerosol containing antibodies or conjugates of a therapeuti c agent with an FcRn binding partner to epithelium of central airways of the lung. The methods and products are adaptable to a wide range of therapeutic agents, including proteins and polypeptides, nucleic acids, drugs, and other s. The methods and products have the advantage of not requiring administration to the deep lung in order to effect systemic delivery. |